Literature DB >> 18441460

Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET.

Yen-Wen Wu1, Masanao Naya, Takahiro Tsukamoto, Hiroshi Komatsu, Koichi Morita, Keiichiro Yoshinaga, Yuji Kuge, Hiroyuki Tsutsui, Nagara Tamaki.   

Abstract

BACKGROUND: The 11C-acetate positron emission tomography can estimate myocardial oxidative metabolism, but previous studies have only evaluated small populations and the difference between ischemic (ICM) and idiopathic dilated cardiomyopathy (DCM) has not been fully investigated. The present aims were to evaluate global and regional myocardial oxidative metabolism in a well-characterized, large population with left ventricular (LV) dysfunction in order to clarify the metabolic differences between ICM and DCM. METHODS AND
RESULTS: Seventy-eight patients with ejection fraction (EF) < or =50% (33 ICM; 45 DCM) were compared with 14 healthy controls. Myocardial oxidative metabolism was estimated with a clearance rate constant (K(mono)) and the coefficient of variation (CV) of regional K(mono). Patients with LV dysfunction had reduced K(mono) and higher CV (p<0.05). In the comparison of oxidative alterations with clinical variables there was a weak correlation between K(mono) and LVEF (r=0.27). Although K(mono) was reduced in both ICM and DCM, CV was more pronouncedly increased in ICM (p=0.001). In multivariate analysis, the presence of left bundle branch block (LBBB) was an independent predictor of heterogeneous oxidative metabolism in DCM (R2=0.30, p<0.0001).
CONCLUSIONS: Global reduction of myocardial oxidative metabolism occurred in both ICM and DCM. Heterogeneous oxidative metabolism was observed in these patients, especially those with ICM. Furthermore, LBBB was the independent predictor of heterogeneous oxidative metabolism in patients with DCM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18441460     DOI: 10.1253/circj.72.786

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

1.  Myocardial oxidative metabolism is increased due to haemodynamic overload in patients with aortic valve stenosis: assessment using 11C-acetate positron emission tomography.

Authors:  Masanao Naya; Satoru Chiba; Hiroyuki Iwano; Satoshi Yamada; Chietsugu Katoh; Osamu Manabe; Keiichiro Yoshinaga; Yoshiro Matsui; Nagara Tamaki; Hiroyuki Tsutsui
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

2.  Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling.

Authors:  Nobuyuki Ohte; Hitomi Narita; Akihiko Iida; Kazuaki Wakami; Kaoru Asada; Hidekatsu Fukuta; Takafumi Kato; Junichiro Hyano; Genjiro Kimura
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

Review 3.  The Modulating Effects of Cardiac Resynchronization Therapy on Myocardial Metabolism in Heart Failure.

Authors:  Yi-Zhou Xu; Chao-Feng Chen; Bin Chen; Xiao-Fei Gao; Wei Hua; Yong-Mei Cha; Petras P Dzeja
Journal:  Pacing Clin Electrophysiol       Date:  2016-12-07       Impact factor: 1.976

4.  11C-acetate PET: A powerful tool to analyze metabolic and functional changes in the heart related to alcohol consumption.

Authors:  John C Stendahl; Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2020-07-16       Impact factor: 5.952

5.  Septal and anterior reverse mismatch of myocardial perfusion and metabolism in patients with coronary artery disease and left bundle branch block.

Authors:  Jian-Guang Wang; Wei Fang; Min-Fu Yang; Yue-Qin Tian; Xiao-Li Zhang; Rui Shen; Xiao-Xin Sun; Feng Guo; Dao-Yu Wang; Zuo-Xiang He
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 6.  Imaging of Myocardial Oxidative Metabolism in Heart Failure.

Authors:  Masanao Naya; Nagara Tamaki
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014

7.  Evaluation of Non-infarct-Related Arteries Using C-11 Acetate PET in STEMI With Multivessel Disease.

Authors:  Sang-Geon Cho; Minchul Kim; Seung Hun Lee; Ki Seong Park; Jahae Kim; Jang Bae Moon; Ho-Chun Song
Journal:  J Cardiovasc Imaging       Date:  2022-07

8.  Radiopharmaceutical tracers for cardiac imaging.

Authors:  Osamu Manabe; Tatsuya Kikuchi; Arthur J H A Scholte; Mohammed El Mahdiui; Ryuichi Nishii; Ming-Rong Zhang; Eriko Suzuki; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2017-12-01       Impact factor: 5.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.